Subscribe to RSS
DOI: 10.5999/aps.2016.43.1.59
Characteristics and Treatment of Cutaneous Melanoma of the Foot
This work was supported by a two-year research grant from Pusan National University.
Background In East Asia, the foot is the most common site of cutaneous melanoma. The purpose of this study was to investigate the differences between cutaneous melanoma of the foot and melanomas of other sites.
Methods We studied 52 patients who underwent surgical treatment for cutaneous melanoma of the foot from September 2000 to January 2015. Through a retrospective review of their medical records, we collected data relating to their sex, age, histopathological subtype, Clark level, tumor thickness, lymph node involvement, stage, and survival rate, and we compared these parameters to those of 61 patients treated for melanoma of other sites. Moreover, we analyzed the surgical procedures, complications, and mortality rates associated with cutaneous melanoma on various parts of the foot.
Results Melanoma of the foot differed from other melanomas only in the histopathological subtype. Other clinical features, including survival rate, did not differ significantly between the two groups heel was the most common site of melanoma of the foot (22 cases, 42.3%). The method of reconstruction varied depending on the region involved.
Conclusions A comparison of melanoma of the foot to other melanomas showed that melanoma of the foot was associated with a significantly different distribution of histological subtypes. Consistent with previous findings, we found that the acral lentiginous subtype was the most common among melanomas of the foot. Furthermore, in contrast with previous studies, we did not find a worse prognosis or lower survival rate for melanoma of the foot in comparison with other melanomas.
Publication History
Received: 08 May 2015
Accepted: 14 July 2015
Article published online:
20 April 2022
© 2016. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Jang KA, Kim JH, Choi JH. et al. A Clinico-histopathological study of malignant melanoma. Korean J Dermatol 2000; 38: 1435-1443
- 2 Choi SJ, Bae YC, Moon JS. et al. An analysis of clinical and histopathological pattern of malignant melanoma. J Korean Soc Plast Reconstr Surg 2007; 34: 557-561
- 3 Park KD, Lee SJ, Lee WJ. et al. clinicopathological features of cutaneous malignant melanoma. Korean J Dermatol 2007; 45: 149-158
- 4 Reintgen DS, McCarty Jr KM, Cox E. et al. Malignant melanoma in black American and white American populations: a comparative review. JAMA 1982; 248: 1856-1859
- 5 Kukita A, Ishihara K. Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J Invest Dermatol 1989; 92 5 Suppl 210s-213s
- 6 Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer 1984; 54: 1482-1488
- 7 Juzeniene A, Baturaite Z, Moan J. et al. Sun exposure and melanomas on sun-shielded and sun-exposed body areas. Reichrath J. Sunlight, vitamin D and skin cancer. New York: Springer; 2013: 1-15
- 8 Miller AJ, Mihm Jr MC. Melanoma. N Engl J Med 2006; 355: 51-65
- 9 Gilchrest BA, Eller MS, Geller AC. et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340: 1341-1348
- 10 Durbec F, Martin L, Derancourt C. et al. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 2012; 166: 727-739
- 11 Green A, McCredie M, MacKie R. et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10: 21-25
- 12 Coit DG, Andtbacka R, Anker CJ. et al. Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013; 11: 395-407
- 13 Park DH, Seo SJ, Park MC. et al. Clinical study of malignant melanoma for recent 14 years. J Korean Soc Plast Reconstr Surg 2009; 36: 299-305
- 14 Gray RJ, Pockaj BA, Vega ML. et al. Diagnosis and treatment of malignant melanoma of the foot. Foot Ankle Int 2006; 27: 696-705
- 15 Sanlorenzo M, Osella-Abate S, Ribero S. et al. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome. Int J Dermatol 2015; 54: 1023-1029
- 16 Talley LI, Soong S, Harrison RA. et al. Clinical outcomes of localized melanoma of the foot: a case-control study. J Clin Epidemiol 1998; 51: 853-857
- 17 Bristow IR, de Berker DA, Acland KM. et al. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res 2010; 3: 25
- 18 Ishihara K, Saida T, Otsuka F. et al. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 2008; 13: 33-41
- 19 Mark WC, Lawrence BC, Christopher EA. et al. Foot reconstruction. Neligan P, Warren RJ, Van Beek A. Plastic surgery. Philadelpia: Elsevier Saunders; 2011: 207-217